Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2006-12-05
2006-12-05
Tsang, Cecilia J. (Department: 1654)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C514S002600, C530S300000, C530S328000
Reexamination Certificate
active
07144864
ABSTRACT:
A novel carboxypeptidase R (CPR) inhibiting peptide is prepared using rational structure-based strategies, incorporating two principle facts: (a) CPR has a strong affinity for basic amino acids and; and (b) the two lysines and arginine residues of PCI are orientated in the same direction and held in close spatial proximity by three disulfide bonds.
REFERENCES:
patent: 5833986 (1998-11-01), LaRochelle et al.
patent: 6020166 (2000-02-01), De Lange et al.
patent: 6051549 (2000-04-01), Roberts et al.
E. Lazoura, et al. Chem. Biol. (2002) 9(10), pp. 1129-1139.
G.M. Hass, et al. Biochemistry (1975) 14(6), pp. 1134-1342.
.R. Leary, et al. Biochemistry (1979) 18(11), pp. 2252-2256.
C. Marino-Buslje, et al. Eur. J. Biochem. (2000) 267, pp. 1502-1509.
M. Nagashima, et al. Thromb. Res. (2000) 98, pp. 333-342.
G.M. Clore, et al. Biochemistry (1987) 26, pp. 8012-8023.
Campbell William
Lazoura Eliada
Okada Hidechika
Okada Noriko
Burns & Levinson LLP
Cohen Jerry
Gaudet Stephen J.
Hidechika Okada
Kosar Andrew D.
LandOfFree
Carboxypeptidase R inhibiting peptide does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Carboxypeptidase R inhibiting peptide, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Carboxypeptidase R inhibiting peptide will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3710822